Adaptimmune Therapeutics (ADAP) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist

0.800
+0.074+10.23%

Close Nov 1 16:00 ET

0.816
+0.016+2.04%

Post 20:01 ET

204.55MMarket Cap-2221P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Adaptimmune Therapeutics PLC - Receives Nasdaq Notice for Non-Compliance With Minimum Bid Price
ReutersNov 1 17:01 ET
Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024
newsfileOct 31 17:20 ET
Express News | Adaptimmune Therapeutics: Entered Mutual Release and Resolution Agreement With Genentech Inc & F. Hoffmann-La Roche Ltd
ReutersSep 23 16:43 ET
Adaptimmune to Participate in Two Bank Conferences This September
newsfileAug 28 08:00 ET
Individual Investors Who Own 39% Along With Institutions Invested in Adaptimmune Therapeutics Plc (NASDAQ:ADAP) Saw Increase in Their Holdings Value Last Week
Simply Wall StAug 27 08:39 ET
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading
MT NewswiresAug 26 11:25 ET

Comments

101674396

Oct 31 03:35

$Adaptimmune Therapeutics (ADAP.US)$ .. green when is the pre-market , will drop once open market!!!

Trytosaveabit

Sep 23 17:44

Newly filed 8K

$Adaptimmune Therapeutics (ADAP.US)$ Item 1.01Entry into a Material Definitive Agreement.
On September 23, 2024, Adaptimmune Therapeutics plc (the “Company”) entered into a Mutual Release and Resolution Agreement (the “Agreement”) with Genentech Inc and F. Hoffmann-La Roche Ltd, (together “Genentech”). The parties entered into the Agreement following notice of termination of their Collaboration and License Agreement dated September 3, 2021 (the “Collaboration Agreement”) on April 8,...

Tonyco

Sep 8 17:22

$Adaptimmune Therapeutics (ADAP.US)$
so the spike in cash is from financing, fyi

Joy Boy or Bringer

Aug 29 12:36

50% at least please

20% before didn't TP. will wait patiently... or maybe CL...
after the product is approved, profitable, it's your time to shine.
$Adaptimmune Therapeutics (ADAP.US)$